Is a complete ETR/SBX research report available?

No complete published report is available for etr/SBX (ETR/SBX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ETR/SBX (ETR/SBX)

Deutsche Börse Xetra: ETR/SBX · EUR

€1.07

-0.13 (-10.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ETR/SBX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	8.2M
Revenue (ttm)	14.9M
Net income (ttm)	-9.7M
EPS (ttm)	-€1.66
Shares out	6.8M
Volume	9,844
Beta	0.68

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 14.9M
Net income (ttm): -9.7M
EPS (ttm): -€1.66
Market cap: 8.2M

All ETR/SBX indicators

Market & fundamental data

Available fields

165

Groups with data

Currency

EUR

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	79
Employees Change	24%
Employees Change Percent	43.64
Enterprise value	EUR 8.3M
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	26.05
Industry PE Fwd	18.2
Isin	DE000A3E5A59
Last refreshed	2026-07-29
Market cap	EUR 8.2M
Price	EUR 1.07
Price currency	EUR
Rev Per Employee	188,076.72x
Sector	Healthcare
Sector PE	41.08
Sector PE Fwd	15.43
Sic	2834
Symbol	etr/SBX
Website	https://www.synbiotic.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-118.45%
EV/Sales	0.56x
FCF yield	-7.98%
P/B ratio	0.39x
P/S ratio	0.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1,804.59%
EBITDA Margin	-1,804.59%
Gross margin	36.44%
Gross Profit	EUR 5.4M
Gross Profit Growth	44.79%
Net Income	EUR -9.7M
Net Income Growth Quarters	2%
Pretax Margin	-73.2%
Profit Margin	-65.39%
Profit Per Employee	EUR -122,990
ROA	-5.07
Roa5y	-8.13
ROCE	-4.37
ROE	-59.95
Roe5y	-51.55
ROIC	-9.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-64.87%
Cagr3y	-39.07%
Cagr5y	-44.23%
EPS Growth Quarters	1
Revenue Growth	171.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.37
Assets	EUR 45.7M
Cash	EUR 690,174
Current Assets	EUR 6.9M
Current Liabilities	EUR 15.5M
Debt	EUR 2.6M
Debt Equity	EUR 0.13
Debt FCF	EUR -4.03
Equity	EUR 21M
Interest Coverage	-3.08
Liabilities	EUR 24.7M
Long Term Assets	EUR 38.8M
Long Term Liabilities	EUR 9.3M
Net Cash	EUR -2M
Net Cash By Market Cap	EUR -23.78
Net Debt Equity	EUR 0.09
Tangible Book Value	EUR -8.4M
Tangible Book Value Per Share	EUR -1.23
WACC	9.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.44
Inventory Turnover	3.32
Net Working Capital	EUR -8.4M
Quick ratio	0.11
Working Capital	EUR -8.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-274.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-64.84%
200-day SMA	2.08
3Y total return	-77.39%
50-day SMA	1.38
50-day SMA vs 200-day SMA	50under200
5Y total return	-94.6%
All Time High	41.8
All Time High Change	-97.43%
All Time High Date	2021-11-30
All Time Low	1
All Time Low Change	7.4%
All Time Low Date	2026-06-26
ATR	0.08
Beta	0.68
Beta1y	0.49
Beta2y	0.81
Ch YTD	-61.91
High	1.26
High52	3.85
High52 Date	2025-12-17
High52ch	-72.07%
Low	1.07
Low52	1
Low52 Date	2026-06-29
Low52ch	7.4%
Ma50ch	-22.12%
Price vs 200-day SMA	-48.32%
RSI	37.45
RSI Monthly	32.74
RSI Weekly	33.12
Sharpe ratio	-0.53x
Sortino ratio	-0.87
Total Return	-274.27%
Tr YTD	-61.91
Tr1m	2.29%
Tr1w	-8.52%
Tr3m	-46.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -3.3M
Operating margin	-22.02

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-351,665
Shares Out	6,824,038

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	2,648.8x
Bv Per Share	3.35
CAPEX	EUR -151,399
Ch1m	2.29
Ch1w	-8.52
Ch1y	-64.84
Ch3m	-46.3
Ch3y	-77.39
Ch5y	-94.9
Ch6m	-57.3
Change	-10.65%
Change From Open	-14.9
Close	1.2
Days Gap	4.99
Depreciation Amortization	758,722
Dollar Volume	10,572.5
Earnings Date	2026-08-17
EBIT	EUR -1.3M
EBITDA	EUR -1.3M
EPS	EUR -1.66
F Score	2
FCF	EUR -654,525
FCF EV Yield	-7.89x
FCF Per Share	EUR -0.1
Financing CF	2,841,732
Fiscal Year End	December
Founded	2,024
Goodwill	26,606,672
Income Tax	EUR 14,152
Investing CF	-2,064,922
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2024-06-30
Ma150	1.99
Ma150ch	-45.95%
Ma20	1.19
Ma20ch	-9.97%
Net CF	453,962
Next Earnings Date	2026-08-17
Open	1.26
Position In Range	1.05
Ppne	5,024,913
Price Date	2026-07-28
Relative Volume	3.85x
Revenue	14,858,061x
Tax By Revenue	0.1x
Tr6m	-57.3%
Volume	9,844
Z Score	-1.09

ETR/SBX (ETR/SBX)

Coverage state: Market snapshot only — no published research

Generate the first ETR/SBX analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/SBX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/SBX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ETR/SBX

Frequently asked questions